Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia?

被引：52

作者：

Ghafar M.A. ^{[1
]}

Puchner P.J. ^{[1
]}

Anastasiadis A.G. ^{[1
]}

Cabelin M.A. ^{[1
]}

Buttyan R. ^{[1
]}

机构：

[1] Department of Urology, College of Physicians and Surgeons of Columbia University, Herbert Irving Pavilion, 11th Floor, 161 FortWashington Avenue, New York, 10032, NY

来源：

Current Urology Reports | 2002年 / 3卷 / 4期

关键词：

Androgen Receptor; Benign Prostatic Hyperplasia; Finasteride; Prostate Gland; Tamsulosin;

D O I：

10.1007/s11934-002-0051-2

中图分类号：

学科分类号：

摘要：

Benign prostatic hyperplasia (BPH) is a disease condition characterized by abnormal prostate growth in conjunction with distinct lower urinary tract symptoms. This paper considers the extent to which the prostatic vascular system contributes to normal prostate growth control as well as whether abnormal blood flow patterns in the aging prostate gland might lead to hypoxia-stimulated prostate growth. This relationship is posited from accumulated research that suggests the prostatic vascular system is a primary androgen action target and other research demonstrating the diverse effects of hypoxia in eliciting cell death or cell growth responses. This hypothesis is further supported by the coincidental clinical finding that the presence of cardiovascular disease conditions are among the general risk factors for the development of BPH, and that cardiovascular-active drugs can be used for the treatment of BPH symptoms. This hypothesis has major implications for our understanding of the etiology of BPH, as well as for the development of new and better treatments for this extremely common condition. © 2002, Current Science Inc.

引用

页码：292 / 296

页数：4

共 22 条

[1]

Jonler M., Riehmann M., Brinkmann R., Bruskewitz R.C., Benign prostatic hyperplasia, Endocrinol Metab Clin North Am, 23, pp. 795-807, (1994)

[2]

Buttyan R., Chen M.W., Levin R.M., Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction, Eur Urol, 32, pp. 32-39, (1997)

[3]

Kyprianou N., Isaacs J.T., Activation of programmed cell death in the rat ventral prostate after castration, Endocrinology, 122, pp. 552-624, (1988)

[4]

Prins G.S., Birch L., Greene G.L., Androgen receptor localization in different cell types of the adult rat prostate, Endocrinology, 129, pp. 3187-3199, (1991)

[5]

Lekas E., Johansson M., Widmark A., Et al., Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration, Urol Res, 25, pp. 309-314, (1997)

[6]

Shabsigh A., Chang D.T., Heitjan D.F., Et al., Rapid reduction in blood flow to the rat ventral prostate gland after castration: preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival, Prostate, 36, pp. 201-206, (1998)

[7]

Shabsigh A., Tanji N., D'Agati V., Et al., Early effects of castration on the vascular system of the rat ventral prostate gland, Endocrinology, 140, pp. 1920-1926, (1999)

[8]

Franck-Lissbrant I., Haggstrom S., Damber J.E., Bergh A., Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats, Endocrinology, 139, pp. 451-456, (1998)

[9]

Hayek O.R., Shabsigh A., Kaplan S.A., Et al., Castration induces acute vasoconstriction of blood vessels in the rat prostate concomitant with a reduction of prostatic nitric oxide synthase activity, J Urol, 162, pp. 1527-1531, (1999)

[10]

Ghafar M.A., Shabsigh A., Anastasiadis A.G., Et al., The effects of castration on the production of vaso-regulatory substances in the rat prostate gland, J Urol, 165, (2001)

← 1 2 3 →